As of August 28, 2026, Integrated BioPharma, Inc. (INBP) has a DilutionWatch DilutionScore of 32/100, rated MEDIUM dilution risk. Integrated BioPharma, Inc. has a market capitalization of $5.59M, 31.06M shares outstanding.
This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.
Score Breakdown
💰Cash Runway—
Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
model est. 32%
🔄 Reverse Split
model est. 55%
• 50-day avg $0.25 below $1 exchange minimum
🔁 Convertible Conversion
model 15%
• Convertible debt present: 7.9% potential dilution
Market Data
Market Cap$5.59M
Shares Outstanding31.06M
Float7.38M
Cash$5.83M
Debt$18.0K
Short InterestN/A
Institutional Holdings
0.1% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
Short Interest
Short Interest1.6K
Days to Cover1.0
% of Float0.0%
FINRA data as of Jul 15, 2026
Recent SEC Activity
xbrl
XBRL CONVERTIBLE
2019-06-30
4
INSIDER TRANSACTION
2026-03-26
4
INSIDER TRANSACTION
2026-03-25
4
INSIDER TRANSACTION
2026-03-25
Full SEC filing analysis available with free account
→
Recent News
No recent news
Factual INBP Dilution Snapshot
Integrated BioPharma, Inc. (INBP) has a DilutionScore of 32/100, rated Medium dilution risk. Score date: August 28, 2026.
- Recent SEC activity tracked for INBP: 4 on 2026-03-26; 4 on 2026-03-25; 4 on 2026-03-25.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Track INBP Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking INBP — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required